Tweets
Low PREVENT Score, Real Risk: Coronary Calcium and Heart Failure in Lupus
Dr. Akhil Sood | Abstracts 2861 0922 | ACR 2026
https://t.co/hREBmSbDQK https://t.co/vI1fjWq4pe
Dr. John Cush @RheumNow ( View Tweet )
10 hours 49 minutes ago
Who gets left behind by the new SpA Criteria
Dr. Henrique Dalmolin & Dr. Carla Saad & Dr. Licia Mota | ACR 2026
https://t.co/SJhUVCZ8aZ https://t.co/vpe7ASo82Q
Dr. John Cush @RheumNow ( View Tweet )
11 hours 49 minutes ago
Biologics vs JAKi: MACE and VTE Risk in PsA
Dr. Sheila Reyes & Dr. Marina Magrey | Abstract 2304 | ACR 2026
https://t.co/IzafHHg9Me https://t.co/PGfQOk882R
Dr. John Cush @RheumNow ( View Tweet )
12 hours 49 minutes ago
ACR 2026: Fibromyalgia Topic Panel https://t.co/buc2fHF7KM
Links:
Dr. John Cush @RheumNow ( View Tweet )
12 hours 49 minutes ago
JAKi CV Safety in Younger Adults
https://t.co/Cp7YEz0277 https://t.co/oBGRQjBuoH
Dr. John Cush @RheumNow ( View Tweet )
13 hours 19 minutes ago
UPSTAND study: widespread pain responding to JAK inhibition
https://t.co/ZGouZSXaXU https://t.co/He2nXncsFF
Dr. John Cush @RheumNow ( View Tweet )
14 hours 49 minutes ago
Who might benefit from GLP-1s in your rheumatology clinic? Join Drs. Catherine Bakewell and Leonard Calabrese at https://t.co/9THCAABeZ0, Jan 30–31 in Dallas, TX, or live online. Kick off 2027 with 12.5 CME credits. Early bird pricing through Dec 15.
https://t.co/xjuAWKqAY9 https://t.co/xhqg94lmoy
Dr. John Cush @RheumNow ( View Tweet )
18 hours 48 minutes ago
Pioneers & Progress in Pediatric Rheumatology: The 50th Anniversary
Dr. Susan Shenoi | "Mastering the Field of Pediatric Rheumatology: Pioneers and Progress, 50th Anniversary" |ACR 2026
https://t.co/hSx8LHR99s https://t.co/cQNLQkT6qp
Dr. John Cush @RheumNow ( View Tweet )
19 hours 48 minutes ago
Not All Pain in Rheumatic Disease is Inflammatory
In a session at the Global Rheumatology Summit, Dr. Daniel Clauw, an expert on the topic, explained that fibromyalgia can occur in isolation in a “top-down” fashion, or can be secondary to inflammatory autoimmune diseases in a https://t.co/AMUm52SKsB
Dr. John Cush @RheumNow ( View Tweet )
21 hours 49 minutes ago
Points to Consider in D2M/Treatment Refractory axSpA
New ASAS guidance presented at #ACR26 outlines 10 points to consider, from diagnostic reassessment to inflammation, mimics & treatment adherence.
Dr. Sheila Reyes breaks it down: https://t.co/vvT2qWbbM7 https://t.co/Crf5uisIvS
Dr. John Cush @RheumNow ( View Tweet )
23 hours 46 minutes ago
To Pulse or Not to Pulse in ANCA Associated Vasculitis?
New #ACR26 data found no significant remission benefit with pulse steroids, but serious infections were higher (31% vs 14%). Is it time to rethink their use?
Dr. Michael Putman weighs in: https://t.co/b6cJkI2aXc https://t.co/rM3eoRBJYW
Dr. John Cush @RheumNow ( View Tweet )
1 day ago
What does CAR-T safety look like between autoimmune disease and heme-onc?
Here's CRS and ICANS within the cohorts so far
(although don't forget about the lymphodepletion)
Anca Askanase @HSpecialSurgery #ACR26 @RheumNow https://t.co/GkDGDiOET4
David Liew @drdavidliew ( View Tweet )
1 day ago
Two Prescriptions, One Patient
Obesity, in particular in PsA was widely covered at #ACR26. In the Swiss SCQM registry, 63.6% of 2,087 patients with PsA were overweight or obese, compared with 31% overweight and 12% obese in the Swiss population, and higher BMI tracked disease https://t.co/Ys5wTvQ2r9
Dr. John Cush @RheumNow ( View Tweet )
1 day ago
ACR 2026 Day 4 Report
The last day of ACR 2026 was a half-day but a busy day, with several exciting reports, especially coming from the late-breaking abstracts.
https://t.co/wBfrQhwZHy https://t.co/plZgG0Y7VN
Dr. John Cush @RheumNow ( View Tweet )
1 day ago
ACR 2026: RA Topic Panel https://t.co/4Jttct8XKe
Links:
Dr. John Cush @RheumNow ( View Tweet )
1 day ago
